Change Or Risk Failure: UK Govt Panel Warning On Life Sciences Industrial Strategy
Executive Summary
The UK government's approach for delivering the much-vaunted Life Sciences Industrial Strategy is too complex and duplicative, a parliamentary committee has suggested. Instead a detailed plan should be developed with clear lines of authority, responsibility and accountability.
You may also be interested in...
UK Industrial Strategy Offers ‘Substantial’ Life Science Investments Through New Sector Deal
The UK government has finally published its Industrial Strategy white paper, which includes a “sector deal” for the life sciences that promises “substantial” private and charitable sector investments.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.